IMMUNITYBIO INC (IBRX)

US45256X1037 - Common Stock

2.62  -0.05 (-1.87%)

After market: 2.6499 +0.03 (+1.14%)

IMMUNITYBIO INC

NASDAQ:IBRX (12/20/2024, 8:17:44 PM)

After market: 2.6499 +0.03 (+1.14%)

2.62

-0.05 (-1.87%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%36.84%
Sales Q2Q%7346.34%
CRS9.52
6 Month-63.91%
Overview
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Ins Owners5.62%
Inst Owners9.08%
Market Cap1.91B
Shares730.16M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.22
Short Float %31.15%
Short Ratio7.12
IPO07-28 2015-07-28
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IBRX Daily chart

Company Profile

ImmunityBio, Inc. is a clinical stage immunotherapy company. The company is headquartered in San Diego, California and currently employs 672 full-time employees. The company went IPO on 2015-07-28. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as infectious diseases. Its platforms and their associated product candidates are designed to attack cancer and infectious pathogens by activating both the innate immune system, including NK cells, dendritic cells, and macrophages, as well as the adaptive immune system comprising, B and T cells, in an orchestrated manner. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA and recombinant protein vaccines, and cell therapies. Its lead biologic commercial product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein.

Company Info

IMMUNITYBIO INC

3530 John Hopkins Court

San Diego CALIFORNIA 92121

P: 18446965235

CEO: Richard Adcock

Employees: 622

Website: https://immunitybio.com/

IBRX News

News Image10 days ago - Market News VideoInvestors Bag IBRX 6.2% Lower Than Its Secondary Stock Offering
News Image11 days ago - D. Boral CapitalD. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
News Image11 days ago - Market News VideoNoteworthy Wednesday Option Activity: PIPR, CRK, IBRX
ChartMill News Image11 days ago - ChartmillWednesday's session: top gainers and losers

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

ChartMill News Image12 days ago - ChartmillWhich stocks are experiencing notable movement on Wednesday?

Which stocks are experiencing notable movement on Wednesday?

ChartMill News Image12 days ago - ChartmillThe market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Gap analysis on 2024-12-11: gap up and gap down stocks in today's session.

IBRX Twits

Here you can normally see the latest stock twits on IBRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example